Viatris recalls

Viatris has 25 recalls on record with the FDA and USDA, the earliest in 2021 and the latest reported on 15 Apr 2026. 12 are still ongoing. 1 was reported in the last 12 months. The most frequent reason is potency & assay.

Total recalls25since 2021

Last 12 months1reported

Class I14% of total

Ongoing12latest 15 Apr 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 11 2Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 1Apr 0 0 0Jul 0 0

Severity split

Class I 1 4%Class II 22 88%Class III 2 8%

Why viatris is recalled

Product types

Brands

By year

202614%
202528%
20241456%
202314%
2022520%
202128%

Ongoing viatris recalls

12 active

Reported	Class	Recall	Company	Reason	Where
15 Apr 2026Drug	CLASS II	Xanax XR, alprazolam, extended-release tablets, 3 mg recalled by ViatrisXanax	Viatris	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets USP, 25 mcg recalled by ViatrisLevothyroxine Sodium	Viatris	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets USP, 75 mcg recalled by ViatrisLevothyroxine Sodium	Viatris	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets USP, 88 mcg recalled by ViatrisLevothyroxine Sodium	Viatris	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets USP, 137 mcg recalled by ViatrisLevothyroxine Sodium	Viatris	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets USP, 175 mcg recalled by ViatrisLevothyroxine Sodium	Viatris	Potency & Assay	Nationwide

All viatris recalls, newest first

25 total

Reported	Class	Recall	Company	Reason	Where
15 Apr 2026Drug	CLASS II	Xanax XR, alprazolam, extended-release tablets, 3 mg recalled by ViatrisXanax	Viatris	Potency & Assay	Nationwide
22 Jan 2025Drug	CLASS II	Cardura XL (doxazosin) extended release tablets 4 mg recalled by ViatrisCardura	Viatris	Potency & Assay	Nationwide
22 Jan 2025Drug	CLASS II	Cardura XL (doxazosin) extended release tablets 8 mg recalled by ViatrisCardura	Viatris	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets USP, 25 mcg recalled by ViatrisLevothyroxine Sodium	Viatris	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets USP, 75 mcg recalled by ViatrisLevothyroxine Sodium	Viatris	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets USP, 88 mcg recalled by ViatrisLevothyroxine Sodium	Viatris	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets USP, 137 mcg recalled by ViatrisLevothyroxine Sodium	Viatris	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets USP, 175 mcg recalled by ViatrisLevothyroxine Sodium	Viatris	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets USP, 112 mcg recalled by ViatrisLevothyroxine Sodium	Viatris	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets USP, 200 mcg recalled by ViatrisLevothyroxine Sodium	Viatris	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.